Therapeutic Nuclear Medicines-Global Market Status and Trend Report 2013-2023
Report Summary
Therapeutic Nuclear Medicines-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Therapeutic Nuclear Medicines industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Therapeutic Nuclear Medicines 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Therapeutic Nuclear Medicines worldwide, with company and product introduction, position in the Therapeutic Nuclear Medicines market
Market status and development trend of Therapeutic Nuclear Medicines by types and applications
Cost and profit status of Therapeutic Nuclear Medicines, and marketing status
Market growth drivers and challenges
The report segments the global Therapeutic Nuclear Medicines market as:
Global Therapeutic Nuclear Medicines Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Therapeutic Nuclear Medicines Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Beta Emitters Therapeutic Nuclear Medicines
Alpha Emitters Therapeutic Nuclear Medicines
Brachytherapy Therapeutic Nuclear Medicines
Global Therapeutic Nuclear Medicines Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals
Ambulatory Surgical Centers
Other
Global Therapeutic Nuclear Medicines Market: Manufacturers Segment Analysis (Company and Product introduction, Therapeutic Nuclear Medicines Sales Volume, Revenue, Price and Gross Margin):
Cardinal Health
Mallkrodt Plc
GE Healthcare
Lantheus Medical Imaging
Bayer AG
Bracco Imaging SpA
Eczacibasi-Monrol Nuclear Products
Nordion
Advanced Accelerator Applications SA
IBA Molecular Imaging
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Therapeutic Nuclear Medicines-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Therapeutic Nuclear Medicines industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Therapeutic Nuclear Medicines 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Therapeutic Nuclear Medicines worldwide, with company and product introduction, position in the Therapeutic Nuclear Medicines market
Market status and development trend of Therapeutic Nuclear Medicines by types and applications
Cost and profit status of Therapeutic Nuclear Medicines, and marketing status
Market growth drivers and challenges
The report segments the global Therapeutic Nuclear Medicines market as:
Global Therapeutic Nuclear Medicines Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Therapeutic Nuclear Medicines Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Beta Emitters Therapeutic Nuclear Medicines
Alpha Emitters Therapeutic Nuclear Medicines
Brachytherapy Therapeutic Nuclear Medicines
Global Therapeutic Nuclear Medicines Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals
Ambulatory Surgical Centers
Other
Global Therapeutic Nuclear Medicines Market: Manufacturers Segment Analysis (Company and Product introduction, Therapeutic Nuclear Medicines Sales Volume, Revenue, Price and Gross Margin):
Cardinal Health
Mallkrodt Plc
GE Healthcare
Lantheus Medical Imaging
Bayer AG
Bracco Imaging SpA
Eczacibasi-Monrol Nuclear Products
Nordion
Advanced Accelerator Applications SA
IBA Molecular Imaging
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF THERAPEUTIC NUCLEAR MEDICINES
1.1 Definition of Therapeutic Nuclear Medicines in This Report
1.2 Commercial Types of Therapeutic Nuclear Medicines
1.2.1 Beta Emitters Therapeutic Nuclear Medicines
1.2.2 Alpha Emitters Therapeutic Nuclear Medicines
1.2.3 Brachytherapy Therapeutic Nuclear Medicines
1.3 Downstream Application of Therapeutic Nuclear Medicines
1.3.1 Hospitals
1.3.2 Ambulatory Surgical Centers
1.3.3 Other
1.4 Development History of Therapeutic Nuclear Medicines
1.5 Market Status and Trend of Therapeutic Nuclear Medicines 2013-2023
1.5.1 Global Therapeutic Nuclear Medicines Market Status and Trend 2013-2023
1.5.2 Regional Therapeutic Nuclear Medicines Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Therapeutic Nuclear Medicines 2013-2017
2.2 Production Market of Therapeutic Nuclear Medicines by Regions
2.2.1 Production Volume of Therapeutic Nuclear Medicines by Regions
2.2.2 Production Value of Therapeutic Nuclear Medicines by Regions
2.3 Demand Market of Therapeutic Nuclear Medicines by Regions
2.4 Production and Demand Status of Therapeutic Nuclear Medicines by Regions
2.4.1 Production and Demand Status of Therapeutic Nuclear Medicines by Regions 2013-2017
2.4.2 Import and Export Status of Therapeutic Nuclear Medicines by Regions 2013-2017
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Therapeutic Nuclear Medicines by Types
3.2 Production Value of Therapeutic Nuclear Medicines by Types
3.3 Market Forecast of Therapeutic Nuclear Medicines by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Therapeutic Nuclear Medicines by Downstream Industry
4.2 Market Forecast of Therapeutic Nuclear Medicines by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF THERAPEUTIC NUCLEAR MEDICINES
5.1 Global Economy Situation and Trend Overview
5.2 Therapeutic Nuclear Medicines Downstream Industry Situation and Trend Overview
CHAPTER 6 THERAPEUTIC NUCLEAR MEDICINES MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Therapeutic Nuclear Medicines by Major Manufacturers
6.2 Production Value of Therapeutic Nuclear Medicines by Major Manufacturers
6.3 Basic Information of Therapeutic Nuclear Medicines by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Therapeutic Nuclear Medicines Major Manufacturer
6.3.2 Employees and Revenue Level of Therapeutic Nuclear Medicines Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 THERAPEUTIC NUCLEAR MEDICINES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Cardinal Health
7.1.1 Company profile
7.1.2 Representative Therapeutic Nuclear Medicines Product
7.1.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Cardinal Health
7.2 Mallkrodt Plc
7.2.1 Company profile
7.2.2 Representative Therapeutic Nuclear Medicines Product
7.2.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Mallkrodt Plc
7.3 GE Healthcare
7.3.1 Company profile
7.3.2 Representative Therapeutic Nuclear Medicines Product
7.3.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of GE Healthcare
7.4 Lantheus Medical Imaging
7.4.1 Company profile
7.4.2 Representative Therapeutic Nuclear Medicines Product
7.4.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Lantheus Medical Imaging
7.5 Bayer AG
7.5.1 Company profile
7.5.2 Representative Therapeutic Nuclear Medicines Product
7.5.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Bayer AG
7.6 Bracco Imaging SpA
7.6.1 Company profile
7.6.2 Representative Therapeutic Nuclear Medicines Product
7.6.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Bracco Imaging SpA
7.7 Eczacibasi-Monrol Nuclear Products
7.7.1 Company profile
7.7.2 Representative Therapeutic Nuclear Medicines Product
7.7.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Eczacibasi-Monrol Nuclear Products
7.8 Nordion
7.8.1 Company profile
7.8.2 Representative Therapeutic Nuclear Medicines Product
7.8.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Nordion
7.9 Advanced Accelerator Applications SA
7.9.1 Company profile
7.9.2 Representative Therapeutic Nuclear Medicines Product
7.9.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Advanced Accelerator Applications SA
7.10 IBA Molecular Imaging
7.10.1 Company profile
7.10.2 Representative Therapeutic Nuclear Medicines Product
7.10.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of IBA Molecular Imaging
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF THERAPEUTIC NUCLEAR MEDICINES
8.1 Industry Chain of Therapeutic Nuclear Medicines
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF THERAPEUTIC NUCLEAR MEDICINES
9.1 Cost Structure Analysis of Therapeutic Nuclear Medicines
9.2 Raw Materials Cost Analysis of Therapeutic Nuclear Medicines
9.3 Labor Cost Analysis of Therapeutic Nuclear Medicines
9.4 Manufacturing Expenses Analysis of Therapeutic Nuclear Medicines
CHAPTER 10 MARKETING STATUS ANALYSIS OF THERAPEUTIC NUCLEAR MEDICINES
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Therapeutic Nuclear Medicines in This Report
1.2 Commercial Types of Therapeutic Nuclear Medicines
1.2.1 Beta Emitters Therapeutic Nuclear Medicines
1.2.2 Alpha Emitters Therapeutic Nuclear Medicines
1.2.3 Brachytherapy Therapeutic Nuclear Medicines
1.3 Downstream Application of Therapeutic Nuclear Medicines
1.3.1 Hospitals
1.3.2 Ambulatory Surgical Centers
1.3.3 Other
1.4 Development History of Therapeutic Nuclear Medicines
1.5 Market Status and Trend of Therapeutic Nuclear Medicines 2013-2023
1.5.1 Global Therapeutic Nuclear Medicines Market Status and Trend 2013-2023
1.5.2 Regional Therapeutic Nuclear Medicines Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Therapeutic Nuclear Medicines 2013-2017
2.2 Production Market of Therapeutic Nuclear Medicines by Regions
2.2.1 Production Volume of Therapeutic Nuclear Medicines by Regions
2.2.2 Production Value of Therapeutic Nuclear Medicines by Regions
2.3 Demand Market of Therapeutic Nuclear Medicines by Regions
2.4 Production and Demand Status of Therapeutic Nuclear Medicines by Regions
2.4.1 Production and Demand Status of Therapeutic Nuclear Medicines by Regions 2013-2017
2.4.2 Import and Export Status of Therapeutic Nuclear Medicines by Regions 2013-2017
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Therapeutic Nuclear Medicines by Types
3.2 Production Value of Therapeutic Nuclear Medicines by Types
3.3 Market Forecast of Therapeutic Nuclear Medicines by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Therapeutic Nuclear Medicines by Downstream Industry
4.2 Market Forecast of Therapeutic Nuclear Medicines by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF THERAPEUTIC NUCLEAR MEDICINES
5.1 Global Economy Situation and Trend Overview
5.2 Therapeutic Nuclear Medicines Downstream Industry Situation and Trend Overview
CHAPTER 6 THERAPEUTIC NUCLEAR MEDICINES MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Therapeutic Nuclear Medicines by Major Manufacturers
6.2 Production Value of Therapeutic Nuclear Medicines by Major Manufacturers
6.3 Basic Information of Therapeutic Nuclear Medicines by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Therapeutic Nuclear Medicines Major Manufacturer
6.3.2 Employees and Revenue Level of Therapeutic Nuclear Medicines Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 THERAPEUTIC NUCLEAR MEDICINES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Cardinal Health
7.1.1 Company profile
7.1.2 Representative Therapeutic Nuclear Medicines Product
7.1.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Cardinal Health
7.2 Mallkrodt Plc
7.2.1 Company profile
7.2.2 Representative Therapeutic Nuclear Medicines Product
7.2.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Mallkrodt Plc
7.3 GE Healthcare
7.3.1 Company profile
7.3.2 Representative Therapeutic Nuclear Medicines Product
7.3.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of GE Healthcare
7.4 Lantheus Medical Imaging
7.4.1 Company profile
7.4.2 Representative Therapeutic Nuclear Medicines Product
7.4.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Lantheus Medical Imaging
7.5 Bayer AG
7.5.1 Company profile
7.5.2 Representative Therapeutic Nuclear Medicines Product
7.5.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Bayer AG
7.6 Bracco Imaging SpA
7.6.1 Company profile
7.6.2 Representative Therapeutic Nuclear Medicines Product
7.6.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Bracco Imaging SpA
7.7 Eczacibasi-Monrol Nuclear Products
7.7.1 Company profile
7.7.2 Representative Therapeutic Nuclear Medicines Product
7.7.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Eczacibasi-Monrol Nuclear Products
7.8 Nordion
7.8.1 Company profile
7.8.2 Representative Therapeutic Nuclear Medicines Product
7.8.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Nordion
7.9 Advanced Accelerator Applications SA
7.9.1 Company profile
7.9.2 Representative Therapeutic Nuclear Medicines Product
7.9.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Advanced Accelerator Applications SA
7.10 IBA Molecular Imaging
7.10.1 Company profile
7.10.2 Representative Therapeutic Nuclear Medicines Product
7.10.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of IBA Molecular Imaging
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF THERAPEUTIC NUCLEAR MEDICINES
8.1 Industry Chain of Therapeutic Nuclear Medicines
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF THERAPEUTIC NUCLEAR MEDICINES
9.1 Cost Structure Analysis of Therapeutic Nuclear Medicines
9.2 Raw Materials Cost Analysis of Therapeutic Nuclear Medicines
9.3 Labor Cost Analysis of Therapeutic Nuclear Medicines
9.4 Manufacturing Expenses Analysis of Therapeutic Nuclear Medicines
CHAPTER 10 MARKETING STATUS ANALYSIS OF THERAPEUTIC NUCLEAR MEDICINES
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
